Research summary ·
Boosting Male Fertility: The Impact of Gonadotropin Therapy on Hypogonadotropic Hypogonadism-A Systematic Review and Meta-Analysis.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This work pooled results from many earlier papers. It looked at men with hypogonadotropic hypogonadism. These men had no sperm in their semen. The team asked if gonadotropin drugs could start sperm making again. They also looked at pregnancy and how long things took. They searched medical databases up to May 16, 2025.
What they found
In all, 50 papers with 1583 men were used. The drugs started sperm making in many men. On average, this took 11.8 months. Many couples who wanted a child got pregnant. On average, this took 19 months from the start. Sperm counts often stayed below normal levels. Even so, some couples got pregnant with no extra help. A mix of gonadotropins worked better than human chorionic gonadotropin alone.
What it means for patients
The authors say these drugs can bring back sperm making. They say the drugs also help couples get pregnant. Mixed gonadotropin drugs seemed to work better. The authors see this mix as the first choice for fertility care. Natural pregnancy was often reached, even with weak sperm.
Why it is not certain yet
Most of the papers in this review were of poor quality. This makes the results less sure. The abstract does not say how well men handled the drugs. A review can only be as good as the papers in it.
Source
Boosting Male Fertility: The Impact of Gonadotropin Therapy on Hypogonadotropic Hypogonadism-A Systematic Review and Meta-Analysis.
PubMed · PMID 41987691We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Male hypogonadism publications